UCLA to lead NIMH-financed autism drug discovery network

04/25/2013 | New York Times (tiered subscription model), The

The National Institute of Mental Health will fund a $9 million effort to develop drugs to treat autism spectrum disorders. Researchers at the University of California, Los Angeles, will coordinate a network of researchers at other academic centers who will quickly identify new and existing compounds that might work against autism. Robert H. Ring, vice president of translational research at patient advocacy group Autism Speaks, will be a member of the panel choosing compounds for testing.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY